Global Preclinical Imaging Market, By Product (CT Imaging, MRI Imaging, PET/SPECT Imaging, Multi-modal Imaging, Optical Imaging, Ultrasound Imaging, Photoacoustic Imaging, Reagents, Services), By Application (Research and Development, Drug Discovery), By End User (Pharma and Biotech Companies, Research Institutes, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Feb 2024

Code : CMI6634

Pages :172

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Preclinical Imaging Market- Recent Developments

Product Launch

On September 05, 2023, Revvity, Inc., a biotechnology company, launched its enhanced imaging portfolio that is designed to drive innovation across diverse applications in preclinical research with the launch of three systems. These new innovations include the next-generation IVIS Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, QuantumTM GX3 microCT structural imaging solution, and Vega ultrasound system.

In May 2022, FUJIFILM VisualSonics Inc., a global leader in ultrahigh frequency photoacoustic and ultrasound imaging systems, introduced the Vevo F2 multi-modal, a groundbreaking photoacoustic and ultrasound imaging system that is designed for preclinical use. The Vevo F2 is the world's first system to offer an ultra-high to low-frequency range (71MHz-1MHz), thereby providing researchers with unparalleled imaging versatility.
In May 2022, Bruker Corporation, a medical device company, launched innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio. The new range of Maxwell 7 Tesla and 9.4 Tesla magnets eliminates the need for liquid Helium or Nitrogen refills, while offering high-field sensitivity and resolution for advanced preclinical MRI and PET/MR research.

Business Development Activities by the Market Players

On June 20, 2023, Motilent Limited, a technology start-up and Minerva Imaging announced a strategic partnership to re-envision the translational research in digestive disease research. Minerva Imaging is a global leader in preclinical in vivo imaging, specializing in advanced techniques including MRI, PET & nuclear medicine in a range of preclinical models.

In April 16, 2023, Scintica, a leading value-added reseller of advanced preclinical research instrumentation, announced a new collaboration with Bioemtech, a company dedicated to desktop SPECT, PET, and optical scanners for use in preclinical research. The partnership aims to expand the availability of Bioemtech's preclinical instruments to research scientists around the world.

In August 2021, Rigaku Corporation, a leading manufacturer of X-ray analysis equipment, acquired all issued shares of MILabs B.V., as part of their full-scale effort to enter the life sciences business. Through this acquisition, Rigaku Corporation will expand its life sciences modality business globally by combining MILabs B.V.s' multi-modality businesses, including PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), optical imaging, and CT (Computed Tomography) equipment for animals, with Rigaku Corporation's original X-ray imaging business for animals.